How Will Auxilium Pharmaceuticals (AUXL) Stock React to FDA's Stendra Approval?

NEW YORK (TheStreet) -- Shares of Auxilium Pharmaceuticals  (AUXL) were flat in morning trading Thursday despite the FDA's approval of the company's erectile dysfunction drug Stendra.

The drug cuts in half the time necessary between taking the pill and engaging in sexual activity. Stendra is the first FDA-approved oral erectile dysfunction drug that one can take approximately 15 minutes before sexual activity. Viagra, Pfizer's (PFE) famous blue pill, can be taken an hour prior to sex.

Auxilium developed the drug in conjunction with VIVUS  (VVUS) .

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Auxilium is currently mulling a $2.2 billion takeover offer from Endo International (ENDP)  that would call off Auxilium's merger with Canadian biotech company QLT  (QLTI) .

AUXL Chart AUXL data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Trade-Ideas: Auxilium Pharmaceuticals (AUXL) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Auxilium Pharmaceuticals (AUXL) Is Today's Strong On High Relative Volume Stock

Health Care Stocks: A Year in Review and Predictions for 2015

Health Care Stocks: A Year in Review and Predictions for 2015

How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action?

How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action?

Stock Market Today: S&P Suffers Worst Day in Six Months as Bears Invade

Stock Market Today: S&P Suffers Worst Day in Six Months as Bears Invade

Stock Market Today: Dow Unloads 300 Points in Broad-Based Selloff

Stock Market Today: Dow Unloads 300 Points in Broad-Based Selloff